ArticleTherapeutic advances in urology

Pembrolizumab and olaparib in a cisplatin-refractory testicular cancer patient with a high TMB: first case report.

Nils C H van Creij et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.